CARA
Cara Therapeutics Inc
Price:  
4.91 
USD
Volume:  
16,860.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA WACC - Weighted Average Cost of Capital

The WACC of Cara Therapeutics Inc (CARA) is 5.8%.

The Cost of Equity of Cara Therapeutics Inc (CARA) is 7.90%.
The Cost of Debt of Cara Therapeutics Inc (CARA) is 5.00%.

Range Selected
Cost of equity 5.50% - 10.30% 7.90%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.6% - 7.0% 5.8%
WACC

CARA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.35 0.97
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 10.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.6% 7.0%
Selected WACC 5.8%